Effect of Febuxostat on Renal Function in Patients With Gout and Moderate to Severe Renal Impairment
Trial · NCT01082640
Adverse events183
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 183
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Blood creatinine increased | Investigations | Placebo | 1 | 32 | |
| other | Blood creatinine increased | Investigations | Febuxostat 30 mg BID | 5 | 32 | |
| other | Blood creatinine increased | Investigations | Febuxostat 40/80 mg QD | 2 | 32 | |
| other | Back pain | Musculoskeletal and connective tissue disorders | Placebo | 1 | 32 | |
| other | Back pain | Musculoskeletal and connective tissue disorders | Febuxostat 30 mg BID | 2 | 32 | |
| other | Back pain | Musculoskeletal and connective tissue disorders | Febuxostat 40/80 mg QD | 2 | 32 | |
| other | Pain in extremity | Musculoskeletal and connective tissue disorders | Placebo | 2 | 32 | |
| other | Pain in extremity | Musculoskeletal and connective tissue disorders | Febuxostat 30 mg BID | 3 | 32 | |
| other | Pain in extremity | Musculoskeletal and connective tissue disorders | Febuxostat 40/80 mg QD | 3 | 32 | |
| other | Renal impairment | Renal and urinary disorders | Placebo | 2 | 32 | |
| other | Renal impairment | Renal and urinary disorders | Febuxostat 30 mg BID | 0 | 32 | |
| other | Renal impairment | Renal and urinary disorders | Febuxostat 40/80 mg QD | 1 | 32 | |
| other | Diarrhoea | Gastrointestinal disorders | Placebo | 4 | 32 | |
| other | Diarrhoea | Gastrointestinal disorders | Febuxostat 30 mg BID | 2 | 32 | |
| other | Diarrhoea | Gastrointestinal disorders | Febuxostat 40/80 mg QD | 4 | 32 | |
| other | Nausea | Gastrointestinal disorders | Placebo | 3 | 32 | |
| other | Nausea | Gastrointestinal disorders | Febuxostat 30 mg BID | 2 | 32 | |
| other | Nausea | Gastrointestinal disorders | Febuxostat 40/80 mg QD | 0 | 32 | |
| other | Vomiting | Gastrointestinal disorders | Placebo | 3 | 32 | |
| other | Vomiting | Gastrointestinal disorders | Febuxostat 30 mg BID | 2 | 32 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01082640/events